Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 2;25(4):104020.
doi: 10.1016/j.isci.2022.104020. eCollection 2022 Apr 15.

Implications of PFAS definitions using fluorinated pharmaceuticals

Emily Hammel  1 , Thomas F Webster  1 , Rich Gurney  2 , Wendy Heiger-Bernays  1
Affiliations

Implications of PFAS definitions using fluorinated pharmaceuticals

Emily Hammel et al. iScience. .

Abstract

There are 9,000+ per- and polyfluoroalkyl substances (PFAS) in existence, which makes studying and regulating PFAS individually, or even as small mixtures, infeasible. Multiple PFAS definitions based on structure have been proposed, yet these definitions do not consider the implications for the full suite of organofluorine chemicals. For example, organofluorine pharmaceuticals, whose use may be essential and are found in human serum and wastewater, are not uniformly identified across all definitions. Using nine definitions prepared by various stakeholders, we screened the 360 organofluorine pharmaceuticals approved and used globally between 1954 and 2021. Definitions ranged in their inclusion of organofluorine pharmaceuticals (1%-100%). The most inclusive definitions include several top prescribed pharmaceuticals, e.g., Prozac and Lipitor. This analysis provides a framework against which organizations can make decisions about how best to proceed when defining PFAS.

Keywords: Chemistry; Organic chemistry; Per- and polyfluoroalkyl substances; Pharmaceutical science; Toxicology.

PubMed Disclaimer

Conflict of interest statement

W.H-B and R.G. are members of the Toxic Use Reduction Institute Science Advisory Board in Massachusetts. The authors declare no other competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Substructures identified among organofluorine pharmaceuticals
Figure 2
Figure 2
Examples of organofluorine pharmaceuticals that meet the nine PFAS definitions (A) Buck et al. includes the contrast agent, perflubron (CAS No. 423-55-2). (B) 2018 OECD and TURA 2021a both include the general anesthetic enflurane (CAS No. 13838-16-9). (C) The 2021 OECD definition includes the antineoplastic alpelisib (CAS No.: 1217486-61-7). (D) Glüge et al. includes the antidiabetic medication gemigliptin (CAS No. 911637-19-9). (E) The TURA 2021b definition includes the cardiac ultrasound imaging agent perflexane (CAS No. 355-42-0). (F) U.S. EPA OPPT includes the ultrasound contrast agent Perflutren (CAS No. 76-19-7). (G) The ≥1 fully fluorinated carbon definition includes the antidepressant fluoxetine (Prozac) (CAS No. 54910-89-3). (H) The “all-organofluorine” and ≥1 fully fluorinated carbon definitions include the cholesterol lowering medication atorvastatin (Lipitor) (CAS No. 134523-00-5).
See this image and copyright information in PMC

References

    1. 116th Congress Text - S.1790 - 116th Congress (2019-2020): National Defense Authorization Act for Fiscal Year 2020. 116th Congress. 2019. https://www.congress.gov/bill/116th-congress/senate-bill/1790/text
    1. Administrative Council on Toxics Use Reduction August 19, 2021 TURA program administrative council meeting. 2021. https://www.turi.org/Calendar/TURA_Administrative_Council_Meeting3
    1. Administrative Council on Toxics Use Reduction December 7, 2021 meeting of the TURA program administrative council. 2021. https://www.mass.gov/news/notice-december-7-2021-meeting-of-the-tura-pro...
    1. Agency for Healthcare Research and Quality Medical expenditure panel survey household component. 2019. https://meps.ahrq.gov/mepsweb/survey_comp/household.jsp - PubMed
    1. Bălan S., Mathrani V., Guo D., Algazi A. Regulating PFAS as a chemical class under the California safer consumer products program. Environ. Health Perspect. 2021;129:1–9. doi: 10.1289/EHP7431. - DOI - PMC - PubMed

LinkOut - more resources